With the aim of investigating the roles of carbohydrates in synapse formation, we have characterized a synapse-specific saccharide at the vertebrate neuromuscular junction. Two lectins of similar specificity (Dolichos biflorus agglutinin, DBA, and Vicia villosa-B, agglutinin, VVA-B,) stain synaptic but not extrasynaptic regions of the rat muscle fiber surface and thus define a synapse-specific carbohydrate. Using these and other probes, we show that the carbohydrate moiety concentrated at the neuromuscular junction resembles Kacetylgalactosamine (GalNAc) linked in the B-anomeric form to the termini of oligosaccharides.
VVA-B, also selectively stains neuromuscular junctions in human, mouse, rabbit, guinea pig, chick, frog, axolotl, snake, fish, and lamprey muscles, a phylogenetic conservatism that suggests a synapse-related role for GalNAc &terminal saccharides. AChE from muscle binds to DBA-and VVA-B,-agarose, and is thereby identified as a glycoconjugate bearing the synapse-specific carbohydrate.
Assay of AChE isoforms reveals that asymmetric, collagen-tailed forms, known to be highly concentrated at the rat neuromuscular junction, bind DBA and VVA-B,, while globular forms, which are more widely distributed, do not. A second class of GalNAc-bearing glycoconjugates is demonstrable immunohistochemically with monoclonal antibodies to stage-specific embryonic antigen (SEA)-3 (Shevinsky et al., 1982) and GM2 (Natoli et al., 1988) , which recognize GalNAc-bearing glycolipids. These antibodies selectively stain neuromuscular junctions, where they recognize glycolipid-like molecules that bind VVA-B, but are distinguishable from AChE. The association of a synapse-specific carbohydrate with at least 2 different synapse-specific molecules raises the possibility that the former plays a role in determining a property that the latter share, such as concentration at the synapse.
The carbohydrate components ofglycoconjugates have long been thought to be involved in a variety of cell-cell interactions, and it has been hypothesized that this is true for synaptic interactions None S-E S-E S-E S-E S-E S-E S-E S-E S-E SrE S>E S>E S>E S>>E * Man, mannose; Glc, glucose; Gal, galactose; Fuc, fucose; GlcNAc, N-acetylglucosamine; GalNAc, N-aeetylgalactosamine; NeuAc, neuraminic (sialic) acid. ! PNA appears to stain presynaptic elements at the neuromuscular junction, as well as synaptic and extrasynaptic portions of the muscle fiber surface (see also Smith and Ko, 1986) . ( Biantennary, galactosylated N-linked oligosaccharides with a bisecting N-acetylglucosamine on the P-linked mannose residue of the core (Cummings and Komfeld, 1982) . d Tri-and tetraantennary glycopeptides, terminated in galactose or N-acetylgalactosamine, and having at least one of the a-linked mannose residues substituted with a fl-GlcNAc at C-2 and C-4 (Cummings and Komfeld, 1982) .
w-aminocaproic acid N-hydroxysuccinimide ester (Enzotin; Enzo-DBA and VVA-B, were conjugated at l-2 mg protein/ml gel to Affigel Biochem, NY). Lectins were dialyzed against 200 mM sodium bicar-15 (Biorad) according to the manufacturer's directions. Coupling was bonate buffer, pH 8.0, and 100 mM GalNAc was added to protect at pH 7.8 in 200 mM HEPESbicarbonate buffer with 100 mM GalNAc. binding sites. Enzotin was dissolved at 1.5 mg/ml in dimethylformAfter 4 hr, unreacted gel was quenched with 100 mM ethanolamine, pH amide, -15°C and added to the lectin solution dropwise with stirring.
8.0. Optimal lectin activity was obtained when the Enzotin : lectin ratio was Monoclonal antibodies to SSEA-3 (Shevinslcy et al., 1982) and SSEA-4 -50: 1. Derivatizations were carried out at room temperature for 4 hr, (Kannagi et al., 1983b) were provided by D. Solter (Wistar Institute, after which the lectins were desalted on Sephadex G-10.
Philadelphia, PA) and also by J. Dodd and T. Jesse11 (Columbia Uni- versity, NY). Blood group A-specific monoclonal antibodies Lu8 1, Cu 1, HHl. and HH5 : Hirohashi et al.. 1985 were provided by S. I. Hakomori (University of Washington, Seattle; WA); CB (Furakawa et al., 1985) was purchased from Immucor (Norcross, GA), anti-Forsmann antigen, M1/22.25 (Stem et al., 1978) was provided by T. Jesse11 and J. Dodd, and anti-GM2 (Natoli et al., 1986) was the gift of P. Livingston (Sloan-Kettering Cancer Center, New York). Antibodies to chondroitin 0-, 4-, and 6-sulfates (Couchman et al., 1984) were the gift of B. Caterson (University of West Virginia, Morgantown, WV). Rabbit antiserum to human erythrocyte AChE was the gift of T. Rosenberry (Case Western Reserve, Cleveland, OH).
Histology. Cryostat sections of unfixed skeletal muscles were prepared and stained essentially as described by Covault and Sanes (1986 Ravdin and Axelrod (1977) was included in either the first or second incubation to mark synaptic sites. Stained sections were mounted in glycerol containing paraphenylenediamine, and viewed with fluorescein and rhodamine optics.
For glycosidase digestion, cryostat sections were incubated with 36 milliunits of ol-N-acetylhexosaminidase from C. lumpas (Miles, Naperville, IL) or P-N-acetylhexosaminidase from jack bean (Sigma) in nH 4.0 citrate buffer for 5 hr. 37°C. or with 36 or 36,000 milliunits of &galactosidase from E. coli (Sigmaj for 30 min to 5 hr at 37°C. Sections tobe stained with antibodies to glycosaminoglycans were treated with chondroitinase ABC as described bv Couchman et al. (1984) . For blocking studies, lectins were mixed with potential inhibitors before being applied to sections. These were: N-acetylgalactosamine, cu-methylmannoside, galactose, glucose, chondroitin sulfate from shark cartilage or bovine trachea, dermatan sulfate from porcine skin, heparin from bovine lung or porcine mucosa, mucin from porcine stomach (all from Sigma), heparan sulfate (Miles), or chemically desulfated chondroitin (prepared from chondroitin sulfate by the method of Danishefsky et al., 1960) . For studies of glycolipids, sections were extracted with chloroform : methanol (2:l) at -70°C for 1545 min, and then rinsed with saline. Treated sections were stained as described above. For electron microscopy, a rat platysma muscle was incubated successively with biotinylated VVA-B, and HRP-conjugated avidin (Cappel Laboratories), then fixed and reacted for peroxidase. Some bundles of fibers were teased from the muscles for light microscopy, while others were refixed in OsO,, dehydrated, and embedded in Araldite for thinsectioning (see Covault and Sanes, 1986 , for details).
Extraction and assay ofAChE. To extract total AChE from muscle, endplate-rich regions (Hall, 1973) of rat diaphragm were homogenized in 4 volumes of a "high-salt" buffer (1 M NaCl, 15 mM HEPES, 1% Triton X-100, 10 mM EGTA, 5 mM N-ethylmaleimide, 2 mM benzamidine, 50 &ml leupeptin, 100 pglml aprotinin) and centrifuged at 40,000 x g, 4°C for 30 min; the supematant was retained. For sequential extraction of AChE forms, the method of Younkin et al. (1982) was used. Muscle was first homogenized in "low-salt" buffer ("high-salt" buffer without NaCl) and centrifuged as above. The supematant containing the globular AChE was removed, and the pellet was resuspended in high-salt buffer, incubated on ice for 60 min, then centrifuged at 40,000 x g for 60 min. The resulting supematant was enriched in asymmetric AChE. AChE was analyzed by velocity sedimentation on 5-20% sucrose gradients, as described by Hall (1973) . AChE activity was assayed by the calorimetric method of Ellman et al. (1961) or by the radiometric method of Johnson and Russell (1975) .
AChE binding to lectins was determined by incubating aliquots of muscle extract with lectin-conjugated agarose. Typically, tests used 100 ~1 of lectin gel in a total volume of 400 ~1. Immediately after adding extract to the gel, the tubes were centrifuged briefly, and an aliquot of the supernatant was removed. The tubes were remixed and then incubated for 4-l 2 hr at 4°C with gentle rocking, after which another aliquot of supematant was removed. The 2 aliquots were assayed for AChE activity, and the difference between them was assumed to represent AChE bound to the gel. Control tubes containing unconjugated gel showed that inactivation of AChE during incubation and nonspecific binding of AChE to gel were insignificant.
Results

Characterization of a synaptic carbohydrate
Cryostat sections of rat diaphragm were incubated with one of a series of biotinylated lectins, then stained with fluoresceinavidin or -streptavidin and rhodamine-cr-bungarotoxin. o-Bungarotoxin binds to acetylcholine receptors (AChRs) in the postsynaptic membrane and so marks synaptic sites. As previously reported (Sanes and Cheney, 1982 ) the lectin DBA stained synaptic sites intensely, but did not detectably stain extrasynaptic portions of muscle fibers or other intramuscular structures, such as blood vessels or nerve trunks ( Fig. 1, a, b) . DBA is known to recognize terminal GalNAc residues (Hammerstrom et al., 1977) and, as expected, its staining of neuromuscular junctions was blocked by 10 mM GalNAc, but not by other monosaccharides (glucose, a-methyl mannoside, galactose, or N-acetylglucosamine, all at 100 mM). HPA and SBA, lectins that are selective for terminal GalNAc but can also bind other saccharides (Pereira and Kabat, 1974; Hammerstrom et al., 1977; Baker et al., 1983 ) stained synaptic sites intensely, but also stained extrasynaptic areas faintly (Fig. 1, c, d) . In contrast, several lectins that recognize other sugar moieties stained both synaptic and extrasynaptic portions of muscle fibers approximately equally ( Fig. 1 , e, A Table 1 ). Together, these results show that while the entire muscle fiber surface is rich in carbohydrate, a terminal saccharide that contains or resembles GalNAc is highly concentrated at the neuromuscular junction.
There are 3 well-defined ways in which GalNAc can be linked to subterminal structures: (1) directly O-linked to serine or threonine residues of proteins, (2) as an a-linked terminal sugar of an oligosaccharide, or (3) as a P-linked terminal sugar. These 3 configurations are found in the human blood group antigens Tn, A, and Cad (or Sda), respectively, and, as such, have been studied in detail (Cartron and Nurden, 1979; Donald et al., 1982; Blanchard et al., 1985; Furukawa et al., 1985; Hirohashi et al., 1985) . Terminal GalNAc residues may also be linked to subterminal sugars by a phosphodiester bond (Balsam0 et al., 1986 ; see also Marchase, 1987) ; however, this linkage has not been well characterized and we do not consider it here. DBA recognizes GalNAc in its 0-, LY-, and P-linked conformations and thus cannot be used to distinguish among them (Etzler et al., 198 1; Blanchard et al., 1983) . This is true for HPA and SBA as well (Pereira and Kabat, 1974; Hammerstrom et al., 1977; Blanchard et al., 1983; Mansson and Olofsson, 1983) . However, several lectins and monoclonal antibodies are available that can differentiate these structures. We used a battery of such reagents to determine the conformation of GalNAc at the neuromuscular junction. The lectins PTA (Appukuttan and Basu, 198 1) and LBL (Roberts and Goldstein, 1984) and the antibody CB (Furukawa et al., 1985) bind to all known blood group A variants, recognizing the terminal ol-GalNAc, and accommodating a wide range of subterminal saccharides. Antibodies Lu8 1, Cu 1, HH 1, and HH5 also bind to cu-GalNAc, but recognize a narrower range of subterminal structures (Hirohashi et al., 1985) . Antibody M1/22.25 recognizes the Forssman antigen, a blood group A-related structure in which a terminal GalNAc is a-linked to a subterminal GalNAc instead of to galactose (Stem et al., 1978) . None of these lectins or antibodies recognize the Cad antigen, but LBL, Figure I . Cross sections of rat skeletal muscle doubly stained with biotinylated lectins or antibodies, followed by fluorescein-avidin or fluoresceinsecond antibody plus rhodamine-a-bungarotoxin.
Fluorescein optics (left panels) shows lectin or antibody staining, while illumination of the same fields with rhodamine optics (right panels) reveals oc-bungarotoxin-stained endplates. a, b, DBA stains synaptic but not extrasynaptic areas. c, d, HPA stains synapses intensely and extrasynaptic surfaces faintly. e, f; PHA-E stains synaptic and extrasynaptic areas to a similar extent. g, h, Antibody Lu8 1 stains neither synaptic nor extrasynaptic portions of the muscle fiber. Bar, 20 ym.
CB, and Lu8 1 are known to recognize the Tn antigen, in addition appropriate control tissues. These results argue that the synaptic to the blood group A antigen (Roberts and Goldstein, 1984;  carbohydrate is neither an a-linked nor an O-linked anomer of Furukawa et al., 1985; Hirohashi et al., 1985) . None of these GalNAc. probes stained either synaptic or extrasynaptic portions of the In contrast, VVA-B, and SSA, lectins that recognize P-GalNAc muscle fiber surface (Fig. 1 , g, h; Table 2 ) although all stained and O-linked GalNAc, but not cu-GalNAc (Bird and Wingham, @we 2. Effects of glycosidase digestion on lectin staining of muscle sections. Sections stained with biotin-lectin, fluoresce&avidin, and rhodamine-cu-bungarotoxin were viewed with fluorescein (a, c, e, g, i-l) or rhodamine (b, d, J; h) optics. Endplates of untreated muscle sections are selectively stained by VVA-B, (a. b). Digestion of sections with a-N-acetylgalactosaminidase does not diminish endplate staining by VVA-B, (c, d) . In contrast, digestion of sections with jack bean B-N-acetylhexosaminidase abolishes VVA-B, staining (e, f), but does not affect staining by con A (i, control; J, digested). fl-Galactosidase had no effect on VVA-B, staining (g, h), but did abolish staining by BNA (k, control; 1, digested), a lectin that recognizes terminal P-galactose. Bar, 20 pm. 1974; Komfeld, 1983, 1984; Piller et al., 1986) , stained synaptic sites selectively (Table 2) . Staining by VVA-B,, which agglutinates both Tn and Cad/Sda erythrocytes strongly, was intense, while staining by SSA, which agglutinates Tn erythrocytes more strongly than Cad&da, was just as specific as VVA-B, and DBA, but weaker. Together with the failure of cu-GalNAc and O-linked GalNAc-specific reagents to stain synapses, these results provide strong evidence that the synapsespecific carbohydrate is a terminal, P-linked GalNAc.
The availability of highly specific glycosidases provides a second, independent approach to the characterization of the GalNAc-containing synaptic carbohydrate. We digested muscle sections with cu-N-acetylgalactosaminidase, fl-N-acetylhexosaminidase, or @-galactosidase, then stained with DBA or VVA-B, to see which enzyme treatment affected staining. a-N-Acetylgalactosaminidase, which cleaves both a-and O-linked GalNAc (Hirohashi, 1985) , had no effect on staining (Fig. 2) . In contrast, P-N-acetylhexosaminidase completely abolished synaptic staining by VVA-B, (Fig. 2, e, j) , but did not affect staining by Con A (Fig. 2, i, j) , RCA, PHA-E, or PNA. @-Galactosidase (at concentrations 1 OOO-fold higher than were used for p-N-acetylhexosaminidase) had no effect on synaptic staining by DBA or VVA-B, (Fig. 2, g, h) , but did abolish staining by PNA (Fig. 2, k, I ), a lectin that recognizes terminal, P-linked galactose. These results confirm that the carbohydrate concentrated at the neuromuscular junction and recognized by DBA and VVA-B, is a terminal P-linked GalNAc.
Staining of neurormuscular junctions by VI/A-B, in rat and other vertebrates
Staining of synaptic sites by VVA-B, was qualitatively indistinguishable from, but somewhat more intense than, staining previously reported (Sanes and Cheney, 1982) for DBA. For this reason, and because VVA-B, proved to be more reliably active than DBA following derivatization to biotin or agarose, we characterized the staining of neuromuscular junctions by this lectin in further detail. Synaptic sites were intensely stained when whole muscles were incubated with biotin-VVA-B, and HRPavidin (Fig. 3, a, b) , demonstrating that a major fraction of the glycoconjugate recognized by this lectin is external to the protein-impermeable plasma membrane. Electron microscopy of muscles stained in this way revealed reaction product concentrated in the synaptic cleft and junctional folds (Fig. 3~) ; perisynaptic areas were occasionally lightly stained, while extrasynaptic surfaces, the Schwann cell surface, and the Schwann cellnerve terminal interface (which is accessible to immunochem- ical reagents; see Covault and Sanes, 1986) were unstained. Thus, VVA-B, binds to a glycoconjugate that is concentrated in the area of apposition between nerve and muscle at the neuromuscular junction. A major fraction of this glycoconjugate is associated with the muscle fiber surface, since the intensity of staining is not detectably decreased in denervated muscle (not shown), but we cannot exclude the possibility that some VVA-B,-binding molecules are also associated with the nerve terminal membrane.
To examine whether the VVA-B,-binding glycoconjugate is a general marker of neuromuscular junctions, we stained cryostat sections of skeletal muscles from a variety of vertebrate species. As summarized in Table 3 , VVA-B, selectively stained synaptic sites in muscles of all major vertebrate classes except chondrichthyes, although in several species extrasynaptic portions of the muscle fiber surface were faintly stained as well (e.g., Fig. 4 ). In rat, we stained a series of muscles that varied in position and fiber-type composition. The specificity of synaptic staining was similar in soleus (a predominantly slow-twitch limb muscle), extensor digitorum longus (a predominantly fast-twitch limb muscle), internal intercostal, external intercostal, platysma, and diaphragm muscles (axial muscles of varying fiber-type proportions). Thus, VVA-B, marks synaptic sites in a variety of vertebrate skeletal muscles.
Lectin receptors
Three types of glycoconjugates are known to bear GalNAc residues linked in the p-anomeric form-glycoproteins, glycolipids, and glycosaminoglycans. We tested synapse-associated molecules in each class for their ability to bind VVA-B, and DBA.
AChE
AChE is an easily assayed glycoprotein that, like VVA-B, and DBA-binding material, is highly concentrated in the basal lamina of the neuromuscular junction. To determine whether VVA-B, or DBA bound AChE, extracts from rat diaphragm were incubated with lectin-agarose, and the fraction of the AChE that bound was determined. A significant fraction of the AChE activity in the extract bound to DBA- (Fig. 5) or VVA-B,-agarose. This binding was inhibited by GalNAc but not by another saccharide, a-methylmannoside. No AChE activity bound to unconjugated agarose. Thus, DBA and VVA-B, recognize AChE from muscle.
In these experiments, less than 20-25% of the AChE in the extract bound to DBA or VVA-B, even when lectin-agarose was added in excess. By contrast, 60-90% of the AChE bound to Con A-agarose and was therefore glycosylated (Fig. 5) . This observation raised the possibility that muscle AChE is heterogeneous in its pattern of glycosylation (see Rotundo, 1984) . AChE is known to exist in several different forms in muscle (reviewed in Massoulie and Bon, 1982) . These forms can be divided into 2 groups, globular and asymmetric. In rat muscle, globular AChE exists as monomers (G,), dimers (G,), or tetramers (G,) of the catalytic subunits, and is present at low levels throughout the muscle fiber. Asymmetric AChE consists of one (A,), 2 (A,), or 3 (A,,) of the G, tetramers covalently linked to Section was stained with biotin-VVA-B,, fluorescein-avidin (a), and rhodamine-a-bungarotoxin (b). Bar, 20 Frn. a collagenlike tail. The asymmetric forms, predominantly A,,, are concentrated at or near the neuromuscular junction (Hall, 1973; Younkin et al., 1982) , and may be anchored in the basal lamina of the synaptic cleft (McMahan et al., 1978) .
To see whether the asymmetric (A) and globular (G) forms of AChE bound differently to VVA-B, and DBA, we used sucrose-gradient centrifugation to analyze AChE applied to and eluted from columns of DBA-or VVA-B,-agarose; peaks of activity sedimenting at 4, 10, 12, and 16 S are known to correspond to the G,, G,, A,, and A,, forms, respectively (Massoulie and Bon, 1982; Fig. 6~ ). Results from a DBA-agarose column are shown in Figure 6b . No AChE activity was eluted with 50 mM cu-methylmannoside, but a peak of activity was eluted with 50 mM GalNAc. When analyzed on a 5-20% isokinetic sucrose gradient, this peak was found to be composed exclusively of asymmetric AChE (A, and A,,; Fig. 6~ ). To insure that asymmetric AChE was selectively bound to, rather than preferentially eluted from, the column, we isolated muscle extracts enriched in either G-forms or A-forms. Low-salt buffers with detergent selectively solubilize the G-forms in muscle, and subsequent extraction of the residual pellet with buffer containing 1 M NaCl solubilizes the A-forms (Younkin et al., 1982; Fig. 7, A, B) . Up to 70% of the AChE activity in the A-rich extracts bound to DBA-or VVA-B,-agarose, whereas no activity from the G-rich extracts bound (Fig. 7, C, D) . This confirms our conclusion that the asymmetric, synapse-specific forms of AChE, but not the globular forms, are recognized by DBA and VVA-B,.
In 2 experiments, we considered the extent to which binding of AChE to VVA-B, and DBA is selective. First, the specific activities of AChE (U/mg protein) in a muscle extract and in the eluate from a lectin-agarose column were determined. A purification of > 200-fold resulted from the chromatographic step, indicating that most proteins in muscle did not bind to the gel. Second, a 1251-glycoprotein fraction from muscle, containing AChE, was iodinated and subjected to chromatography on VVA-B,-agarose. Approximately 20% of the AChE applied, but ~0.1% of the 12SI-labeled material bound to the column and was eluted by GalNAc (Fig. 8) . Thus, as expected from the histochemical results, VVA-B,-binding material comprised only a small portion of the glycoproteins present in the muscle extract. A synaptic glycolipid. Globoseries glycolipids and gangliosides that terminate in P-GalNAc are known to be membrane components in a variety of tissues, including muscle (Svennerholm et al., 1972; Chien and Hogan, 1983) . We therefore stained sections of rat muscle with 3 monoclonal antibodies to GalNAccontaining lipids: anti-stage-specific embryonic antigens @SEA)-3 and -4 (Shevinsky et al., 1982; Kannagi et al., 1983a) , and anti-GM2 (Natoli et al., 1986) . GM2 has the structure GalNAcfil -4[NeuAca2-31 GalPl -1Ceramide; anti-SSEA-3 binds to globoseries glycolipids with the common structure R-3GalNAc@1-3Galal-4R', as well as to some glycoproteins; and anti-SSEA-4 binds to glycolipids in which the SSEA-3 antigen is extended by a galactose and a sialic acid residue (R= NeuAccu2-3Gal/31-3).
Anti-SSEA-3 selectively stained synaptic sites in rat skeletal muscle (Fig. 9, a, b) ; nonsynaptic portions of the muscle fiber, and intramuscular structures such as blood vessels and nerve trunks, were very faintly stained. Anti-GM2 also stained synaptic but not extrasynaptic portions of the muscle fiber surface (not shown). Synaptic sites were occasionally stained by anti-SSEA-4, but staining was too faint to be characterized. Staining by anti-SSEA-3 and anti-GM2 (but not by VVA-B,) was abolished by pretreatment of sections with chloroform-methanol (Fig. 9, c, u' ), which selectively extracts lipids and is commonly used as a diagnostic test for their presence (see, for example, Dodd et al., 1984) . Thus, glycolipid-like molecules bearing P-GalNAc residues are concentrated at the neuromuscular junction.
To ask whether the synaptic antigens recognized by anti-SSEA-3 or anti-GM2 are VVA-B,-binding glycoconjugates, we preincubated muscle sections with 1 mg/ml unconjugated VVA-B,, then stained the sections with antibody. VVA-B, blocked endplate staining with anti-SSEA-3 (Fig. 9, e, f) and anti-GM2, demonstrating that the lectin recognizes the same synaptic molecules as do anti-SSEA-3 and anti-GM2, or closely associated ml Figure 8 . Separation of AChE from other glycoproteins by chromatography on VVA-B,-agarose. A diaphragm muscle was homogenized, iodinated with 125I using chloromine T, and extracted with Triton plus high-salt buffer (see Materials and Methods). The extract was fractionated on Con A-agarose to isolate glycoproteins. Material eluted with 500 mM a-methylmannoside, the glycoprotein fraction, was applied to a VVA-B,-agarose column. Little 12jI but -20% of the AChE applied was retained by the column and eluted by GalNAc.
molecules. Do these antibodies recognize AChE? Synaptic sites were intensely stained by anti-AChE antiserum (and by all of a large number of antibodies to known glycoprotein components of the muscle membrane and basal lamina) following chloroform-methanol treatment of sections, while staining by anti-SSEA-3 and anti-GM2 was abolished. Furthermore, removal of the muscle fiber plasma membrane by damage-induced degeneration of muscle (Sanes and Hall, 1979) abolished anti-SSEA-3 and anti-GM2-like immunoreactivity without greatly affecting the intensity of staining by anti-AChE or other antibodies to BL. VVA-B, staining survived both of these treatments. Thus, AChE and glycolipid-like molecules are distinct receptors for VVA-B, at the neuromuscular junction.
Glycosaminoglycans
The glycosaminoglycan chondroitin is composed of the repeating disaccharide (GalNAQl-4Glucuronate@l-3). Because skeletal muscle is known to synthesize chondroitin and its sulfated derivatives (Ahrens et al., 1977; Carrino and Caplan, 1982) we asked whether these structures are recognized by DBA or VVA-B,. First, we mixed chondroitin, chondroitin-4-sulfate, chondroitin-6-sulfate, or dermatan sulfate (chondroitin sulfate B) with biotinylated lectin to see whether this would block its staining of neuromuscular junctions. In addition, we tested heparin and heparan sulfate in light of a report that a GalNAc-inhibitable lectin isolated from chick embryos binds heparin (Ceri et al., 198 1) . However, none of these glycosaminoglycans, at concentrations of up to 1 mg/ml, detectably affected staining by DBA or VVA-B,, whereas 10 pg/ml of porcine gastric mucin, which is rich in terminal GalNAc (Hounsell and Feizi, 1982) completely blocked staining. Second, we stained muscles with a series of 3 monoclonal antibodies (lB5, 9A2, and 3B3) that recognize chondroitin, chondroitin-4-sulfate, and chondroitin-6-sulfate, respectively (Couchman et al., 1984) . Dermatan sulfate is also recognized by 9A2; this sulfate is the only GalNAcrich glycosaminoglycan other than the chondroitins. None of these antibodies stains the neuromuscular junction selectively:
anti-chondroitin-6-sulfate ( Fig. 10 ) and anti-chondroitin stained both synaptic and extrasynaptic areas, while anti-chondroitin-4-sulfate stained neither synaptic nor extrasynaptic areas. Thus, VVA-B, and DBA appear not to recognize the P-GalNAc in chondroitin, and chondroitin appears not to be concentrated at the neuromuscular junction.
Discussion
The histochemical evidence that the synapse-specific carbohydrate initially defined by DBA (Sanes and Cheney, 1982 ) is a P-GalNAc-terminated saccharide can be summarized as follows: (1) Lectins specific for GalNAc stain synaptic sites specifically, lectins that prefer GalNAc to galactose stain synaptic sites more intensely than they do extrasynaptic areas, and lectins that do not recognize GalNAc do not distinguish between synaptic and extrasynaptic areas. (2) Lectins and antibodies that recognize ol-GalNAc and/or O-linked GalNAc, but not P-GalNAc, do not stain synaptic sites. (3) Lectins that recognize /3-GalNAc and O-linked GalNAc but not ol-GalNAc stain synaptic sites selectively. (4) A lectin that prefers O-linked GalNAc to P-GalNAc, but that recognizes both, stains synaptic sites selectively but weakly. (5) Staining of synapses by VVA-B, or DBA is abolished by pretreatment of sections with /3-N-acetylhexosaminidase but not by a-N-acetylgalactosaminidase (which cleaves both oc-GalNAc and O-linked GalNAc) or P-galactosidase. This evidence is limited by the incompletely defined specificities of the probes we used (see, for example, Debray et al., 198 I) , and we cannot exclude the possibility that other sugars or GalNAc in other linkages (e.g., the phosphodiester linkage; Balsam0 et al., 1986) contribute to the synapse-specific carbo- hydrate. Nonetheless, the consistent results obtained with a variety of reagents give us some measure of confidence in our conclusion.
Using VVA-B,, we have shown that terminal GalNAc residues are concentrated at neuromuscular junctions in several mammals and in representatives of 6 of the 7 major vertebrate classes (see Storer et al., 1972) . In some species, including humans, staining of extrasynaptic as well as synaptic areas is detectable, but in each case binding sites are considerably enriched at the synapse. One exception to this generalization is Torpedo, in which both synaptic and extrasynaptic areas are stained by VVA-B,. While we have no explanation for this difference between Torpedo and other vertebrates, it is possible that P-GalNAc is concentrated at synapses but that another VVA-B,-binding glycoconjugate (e.g., one containing O-linked GalNAc) is present throughout the muscle fiber surface. In any event, the conservation of GalNAc as a selective marker of synaptic sites in the muscles of all but one of the 12 species tested is in marked contrast with the variability of glycosylation patterns typically described in such comparative studies (see, for example, Holthoffer, 1983; Kobata, 1984; Mohan and Spiro, 1986 ). This conservation argues that the association of P-GalNAc with the synapse is of some functional significance.
Using lectin-agarose conjugates, we have demonstrated that asymmetric, collagen-tailed AChE binds to DBA and VVA-B,, while globular AChE does not. AChE is highly concentrated at synaptic sites in rat muscle, but some enzyme is present extrasynaptically. The synapse-associated AChE is predominantly asymmetric, while the extrasynaptic enzyme is predominantly globular (Hall, 1973; Younkin et al., 1982) . Thus, DBA and VVA-B, recognize a synapse-specific form of a synapse-associated molecule. An obvious possibility is that these lectins bind to the collagenous tail that constitutes the distinguishing characteristic of asymmetric AChE. It is also possible, however, that the lectins recognize the globular, catalytic subunit or a hitherto unidentified AChE-associated moiety; evidence for heterogenity of catalytic subunits (Doctor et al., 1983) and for the existence of additional subunits (Lee et al., 1982) has been reported for Torpedo AChE. Furthermore, in all of our experiments, a fraction of the asymmetric enzyme remained unbound to lectin. Whether incomplete binding is simply a consequence of the conditions of our assay, or whether it represents heterogeneity within the asymmetric pool (Barat et al., 1984) remains to be determined.
By using 2 antibodies, anti-SSEA-3 and anti-GM2, that recognize P-GalNAc-terminated glycolipids, we defined a novel antigen concentrated at the neuromuscular junction. The abolition of staining by chloroform-methanol, the fine distribution of the antigen, and the known specificity of these antibodies for glycolipids all suggest that the neuromuscular antigens recognized by these antibodies are glycolipids. Abolition of SSEA-3-and GM2-like immunoreactivity by treatments that spare AChE and VVA-B,-binding sites, and inhibition of staining by VVA-B, demonstrate that the glycolipid-like antigens bear the synapse-specific carbohydrate but are distinct from AChE. We do not know, however, whether anti-SSEA-3 and anti-GM2 bind to the same or to different glycolipids: it is unclear whether anti-SSEA-3 recognizes GM2 or whether anti-GM2 might recognize some variants of SSEA-3 (Kannagi et al., 1983a, b; Natoli et al., 1986) . Experiments to characterize the glycolipid(s) at the neuromuscularjunction are now in progress. While no glycolipid has hitherto been shown to be concentrated at the neuromuscular junction, it is interesting that Obata et al. (1977) showed that the glycolipid globoside, which is recognized by anti-SSEA-3 (Kannagi et al., 1983a; Tippett et al., 1986) can perturb normal synaptogenesis when added to nerve-muscle cocultures. Furthermore, anti-SSEA-3 has been shown to stain a restricted subset of sensory neurons in dorsal root ganglia, consistent with the suggestion that globoseries glyclipids may serve as "differentiation antigens" both within and outside of the nervous system (Dodd et al., 1984) .
The result that 2 molecules share a synapse-specific localization and a synapse-specific carbohydrate invites speculation that these attributes are causally related. It is unlikely that the glycosylation results from synaptogenesis, because VVA-B, stains extrasynaptic areas in embryonic and denervated muscles (L. C. Scott and J. R. Sanes, unpublished observations). Alternatively, the synapse-specific carbohydrate might result in preferential localization at synaptic sites via interaction of P-GalNAc-bearing molecules with intracellular or extracellular P-GalNAc-binding molecules (endogenous lectins; see Lis and Sharon, 1986) . One precedent for this is the targeting of acid hydrolases to the lysosome. Several lysosomal enzymes acquire the same unusual saccharide, a terminal mannose-6-phosphate, as they are synthesized. This carbohydrate serves as a common marker: an endogenous mannose-6-phosphate receptor binds these hydrolases and directs their transport to lysosomes (Sahagian, 1987) . Thus, it is clear that carbohydrate structures can be involved in directing the movements of glycoconjugates, and it is reasonable to imagine that other targeting systems, with their own carbohydrate markers, exist (see Lis and Sharon, 1986) . If this hypothesis were true, other synapse-specific molecules would bear the synapse-specific carbohydrate shared by AChE and the synaptic glycolipids.
